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ABSTRACT
Background    To clarify the pathogenesis of cerebel-
lar Purkinje cell death in patients with Menkes kinky 
hair disease (MD), a disorder of copper absorption, we 
investigated the morphological and functional abnor-
malities of residual Purkinje cells in MD patients and 
the mechanism of cell death. 
Methods    Seven MD patients and 39 neurologically 
normal autopsy cases were studied. We performed his-
topathological and quantitative analyses of the Purkinje 
cells. In addition, we used immunohistochemistry to 
detect copper-dependent enzymes [cytosolic Cu/Zn-
superoxide dismutase (SOD1) and copper chaperone for 
superoxide dismutase (CCS)], oxidative stress markers 
[4-hydroxy-2-nonenal (HNE) and acrolein] and heat 
shock protein (hsp) 32. 
Results    The surviving MD Purkinje cells showed 
abnormal development, such as somatic sprouts and 
heterotopic location. Due to maldevelopment and de-
generation, dendrites showed the cactus and weeping 
willow patterns. Axonal degeneration led to the forma-
tion of torpedoes. Quantitative analysis revealed loss of 
approximately 50% of the Purkinje cells in MD patients. 
Almost all of the normal Purkinje cells were positive for 
immunostaining by anti-CCS and anti-SOD1 antibod-
ies, with staining of the cell bodies, dendrites and axons. 
Normal Purkinje cells were not stained by antibodies for 
HNE, acrolein or hsp 32. In MD patients, the majority 
of Purkinje cells were positive for CCS, but the positive 
rate for SOD1 was only about 23%. Approximately 56%, 
42% and 40% of the Purkinje cells of MD patients were 
positive for HNE, acrolein and hsp 32, respectively.  
Conclusion    In MD patients, about 50% of the Pur-
kinje cells have been lost due to maldevelopment and 
degeneration. In the residual Purkinje cells, CCS expres-
sion seems to be nearly normal as a protective response 
to decreased SOD1 activity due to copper deficiency. Be-
cause oxidative stress is elevated secondary to decreased 
SOD1 activity, hsp 32 is induced as another protective 
mechanism. 
 
Key words    copper chaperone for superoxide; cytosolic 
Cu/Zn-superoxide dismutase; immunohistochemistry; 
Menkes kinky hair disease; Purkinje cell 
 
Menkes kinky hair disease (MD) is a sex-linked in-
herited disorder that is characterized by the onset of 
seizures, developmental retardation and typical changes 
of the hair in early infancy.1–5 MD patients develop neu-
ropathological abnormalities throughout the central ner-
vous system.4–7 In the cerebellar cortex, there is marked 
loss of Purkinje cells, while the surviving Purkinje 
cells display characteristic somatic sprouts and bizarre 
thickening of the dendritic tree.4, 5, 8–10 Several studies 
have shown that severe hypocuprinemia occurs in MD 
patients due to impaired absorption of copper from the 
intestine, which causes inactivation of copper-dependent 
enzymes such as cytosolic Cu/Zn-binding superoxide 
dismutase (SOD1).11  
 SOD1 is usually a dimer of 2 identical monomers 
with a molecular weight of approximately 16 kDa, and 
is mainly localized to the cytoplasm. Each SOD1 mono-
mer contains one Cu ion and one Zn ion. SOD1 is an 
antioxidant metalloenzyme that catalyzes the conversion 
of 2 superoxide radicals (O2•–) to 1 molecule each of 
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H2O2 and O2.12, 13 An O2•– is formed when an oxygen 
molecule accepts an additional electron. Superoxide 
radicals cause oxidative damage to the nuclei, organelles 
and enzymes of cells, by reacting with nucleic acids in 
the nuclei, proteins that compose cytoplasmic organelles 
and proteins of enzymes, respectively. Under normal 
conditions, the copper ion of SOD1 exists in the diva-
lent state. When this Cu2+ of SOD1 reacts with an O2•–, 
it undergoes reduction to a Cu+ by gaining an electron 
from the superoxide radical, while the radical that react-
ed with the Cu2+ of SOD1 is converted to O2. Then the 
Cu+ of SOD1 is oxidized again to return to its original 
divalent state as it supplies an electron to another O2•–. 
This other O2•– that receives an electron from the Cu+ of 
SOD1 is converted to H2O2 by reacting with 2H+. Thus, 
SOD1 catalyzes the conversion of 2 O2•– to 1 molecule 
of H2O2 and 1 molecule of O2.12, 13 The H2O2 generated 
by this reaction is ultimately transformed into H2O and 
O2 by enzymes such as catalase, glutathione peroxidase 
and peroxiredoxin.13–15
 The yeast copper chaperone (LSY7: 249 amino 
acids) and the mammalian copper chaperone for super-
oxide dismutase (CCS: 274 amino acids) have both been 
identified.16 The RNA for CCS is encoded by a single-
copy gene on chromosome 11, and CCS expression has 
been found in all human tissues and cells examined.16, 17 
CCS specifically transfers copper ions to SOD1, result-
ing in its activation.16, 18 Since there are no free copper 
ions in vivo,19 SOD1 cannot obtain copper without CCS 
and cannot be activated, so the delivery of copper to 
SOD1 by CCS is essential for its normal activity.20
 Extracellular copper ions are transported into the 
cytoplasm by copper transporter 1 located in the cell 
membrane.21, 22 CCS has 3 domains, among which do-
main I contains a copper-binding site for the copper ions 
that it transports. Copper ions that bind to domain I are 
transferred to domain III via domain II. Domain II of 
CCS shows structural similarity to SOD1 at the molecu-
lar level and contains the coupling region for binding 
with SOD1. After the copper ion is transferred from the 
copper-binding site on domain I to the copper-binding 
site on domain III, it is supplied to SOD1.
 Therefore, CCS has an important, though indirect, 
role in fighting oxidative stresses. Immunohistochemical 
studies have shown that CCS is extensively distributed 
throughout the normal central nervous system, includ-
ing the cerebellar Purkinje cells, similar to SOD1.17 
Decreased SOD1 activity due to impaired absorption 
of copper could cause cellular damage in MD patients, 
with oxidative stress leading to oxidation of membrane 
lipids and the production of toxic aldehyde metabolites 
such as 4-hydroxy-2-nonenal (HNE) or acrolein. Fur-
thermore, heat shock protein (hsp) 32 would be induced 
in response to the increase of oxidative stress.
 In MD patients, copper deficiency could be ex-
pected to lead to Purkinje cell damage due to oxidative 
stress. In the present study, we performed an immuno-
histochemical analysis of cerebellar CCS and SOD1 as 
copper-dependent enzymes, HNE and acrolein as mark-
ers of oxidative stress and hsp 32 as a stress protein. We 
also carried out a quantitative analysis of the number of 
Purkinje cells in the cerebellum. Our objectives were to 
clarify the morphological and functional abnormalities 
of Purkinje cells in MD patients and the pathogenesis of 
these Purkinje cell changes.
 
MATERIALS AND METHODS
Subjects and neuropathologic examination
This study was carried out on brain tissues obtained at 
autopsy from 7 patients with Menkes kinky hair disease 
(MD). The main characteristics of these 7 patients are 
summarized in Table 1. Histologically normal brains 
from 39 other autopsy patients (ages: 1–59 years) served 
as the controls. After fixation in 10% buffered formalin, 
the brain stem and cerebellum were removed from the 
cerebrum at the midbrain level. Routine coronal slices 
of the cerebrum and sagittal and transverse slices of 
the cerebellum were cut. The thickness of these slices 
was about 5 mm and each slice completely transected 
the cerebrum and cerebellum. Slices of the cerebellum 
were embedded in paraffin and then were cut into 6-μm 
thick sections, which were stained by using the fol-
lowing routine methods: hematoxylin and eosin (HE), 
Klüver-Barrera, Holzer, Bodian and modified Hirano-
Bielschowsky stains. Representative paraffin sections 
were used for the immunohistochemical analyses. The 
protocol of this study was approved by the Ethics Com-
mittee of Tottori University (No. 1994: 2012).
 
Quantitative analysis of cerebellar Purkinje cells
We performed quantitative analysis of the number of 
Purkinje cells in the cerebellum using HE-stained sagit-
tal and transverse sections of the cerebellar hemisphere 
and vermis on glass slides (Fig. 1A). The number of Pur-
kinje cells was counted within a 3 mm length, as shown 
in Fig. 1B. For determining the 3 mm length of the circle 
in Fig. 1A, we used a light microscope (Olympus BX-50 
F4, Tokyo, Japan) equipped with an eyepiece microm-
eter grid (24-#10/10X10, Olympus), in combination with 
the stage micrometer (AX0001, OB-M, Olympus). To 
determine the number of Purkinje cells, we counted the 
number of these cells with nuclei. As shown in Fig. 1B, 
we counted the number of Purkinje cells within this 3 
mm length using a measuring device (Erma, Tokyo, 
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Japan). In each autopsy case, these circles including the 
3 mm length (Fig. 1A) were selected randomly at 15 to 
80 sites on HE-stained sections of the cerebellar hemi-
sphere and vermis on glass slides. Then we determined 
the mean number of Purkinje cells per 3 mm length for 
each autopsy case.
 
Immunohistochemistry
The following primary antibodies were used: an affinity 
purified rabbit antibody directed against human copper 
chaperone for superoxide dismutase (CCS) [diluted 1:500 
in phosphate-buffered saline with 1% bovine serum 
albumin (BSA-PBS), pH 7.4],23, 24 a rabbit polyclonal 
antibody for human SOD1 (diluted 1:3,000),12, 14, 15, 23, 
25–29 an affinity purified rabbit antibody targeting 4-hy-
droxy-2-nonenal (HNE) (diluted 1:400; JaICA, Fukuroi, 
Japan), a rabbit polyclonal antibody for acrolein (diluted 
1:3,000; JaICA) and a rabbit polyclonal antibody direct-
ed against hsp 32 (diluted 1:200; Santa Cruz, Dallas, 
TX). The specificity of these antibodies for immunohis-
tochemical detection of the respective epitopes in paraf-
fin sections of human materials has been documented 
previously.12, 14, 15, 23–29
 Sections were deparaffinized, and endogenous per-
oxidase activity was quenched by incubation for 30 min 
with 0.3% H2O2. Then the sections were washed in PBS 
(pH 7.4). Normal serum homologous to each secondary 
antibody was used as the blocking agent. Sections were 
incubated with the primary antibodies for 18 h at 4°C and 
sections incubated with PBS served as controls. Bound 
antibodies were visualized by the avidin-biotin-immuno-
peroxidase complex (ABC) method using the appropriate 
Vectorstain ABC kit (Vector Laboratories, Burlingame, 
CA) and 3,3'-diaminobenzidine tetrahydrochloride  (Dako, 
Glostrup, Denmark).
 The cellular structures on immunostained sections 
were observed under a light microscope (Olympus BX-
50 F4) and mapped, and photomicrographs were obtained 
using a digital camera (Olympus DP12). Then representa-
tive immunostained sections were also subjected to HE 
staining.
 To assess immunostaining of the Purkinje cells in the 
cerebellum by each antibody, 1,000 Purkinje cells were 
examined. Cells that were immunoreactive to the respec-
tive primary antibodies were considered to be positive and 
the proportion of antibody-positive cells was expressed as 
a percentage.
 
Fig. 1. Diagram of the method for quantitative measurement of the number of Purkinje cells in the cerebellum.
A: Sagittal section of the cerebellar hemisphere. The circle shown in A involves a 3 mm length of the Purkinje cell layer. The circled 
area was used for quantitative determination of the number of Purkinje cells. In each autopsy case, at least 15 sites were randomly 
selected from a sagittal section of the cerebellar hemisphere, and the number of Purkinje cells was counted in each area.
B: An enlarged image of the circle shown in A. We measure a 3 mm length (indicated by 3 mm in B) in the cerebellar Purkinje cell 
layer and count the number of red-stained Purkinje cells within this 3 mm length. For example, there are 20 Purkinje cells in B.
Table 1. Characteristics of the 7 patients with Menkes kinky hair disease
 Patient 1 Patient 2 Patient 3 Patient 4 Patient 5 Patient 6 Patient 7
Age at death 1 yr 1 mo 1 yr 4 mo 1 yr 6 mo 1 yr 6 mo 1 yr 9 mo 2 yr 1 mo 6 yr 4 mo
Brain weight (g) 650 500 700 580 450 720 1,130
Family history – – – +* + +* ?
Reference number 4, 5, 36, 37 4, 5 4, 5, 36, 37 4, 5, 36, 37 4, 5, 36, 37 4, 5, 36, 37 4, 5, 38
*sibling; –, absent; +, present; ?, unknown.
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Fig. 2. Histologic features of Purkinje cells in a normal control autopsy case (A) and an MD patient (B–G).
A: Cerebellum of a normal control autopsy case.
B: Cerebellum of an MD patient. Compared with the normal cerebellum, the cerebellum of the MD patient shows severe loss of Pur-
kinje cells (arrowheads in A and B) and marked reduction of granule cells (GC in A and B). As a result, there is a marked decrease 
in the width of the molecular cell layer (arrows in A and B). Panels A and B are at the same magnification (HE stain). Bars = 200 μm (A 
and B).
C: The residual Purkinje cells of the MD patient show somatic sprouts (arrows) (HE stain). Bar = 50 μm.
D: Surviving Purkinje cells of the MD patient exhibit cactus-like change (arrowhead and C) and dendritic expansion (arrowhead) (HE 
stain). Bar = 50 μm.
E: Residual Purkinje cells of the MD patient display a weeping willow dendritic pattern (double arrowheads) (HE stain). Bar = 50 μm.
F: In the MD patient, ectopic Purkinje cells bearing somatic sprouts (arrows and H) are found in the granule cell layer (HE stain). Bar 
= 50 μm.
G: A residual Purkinje cell of the MD patient shows an axonal torpedo (arrowhead) (HE stain). Bar = 50 μm.
HE, hematoxylin and eosin; MD, Menkes kinky hair disease. 
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Statistical analysis 
IBM SPSS Statistics software (IBM, Chicago, IL) was 
used for statistical analysis. The number of Purkinje 
cells is presented as the mean ± SE. For analysis of all 
data, non-parametric Kruskal-Wallis analysis of vari-
ance (ANOVA) was performed, followed by a non-para-
metric Wilcoxon rank-sum test. Statistical significance 
was accepted at P < 0.05.
RESULTS
Neuropathological findings 
Comparison between the 39 normal control autopsy 
cases (Fig. 2A) and the 7 MD autopsy cases (Fig. 2B) 
revealed severe loss of Purkinje cells and marked reduc-
tion of granule cells (Fig. 2B) in the cerebellum of the 
MD patients. The loss of Purkinje cells in MD patients 
was accompanied by prominent Bergmann gliosis in the 
Purkinje cell layer. In all 7 MD patients, the width of the 
molecular layer of the cerebellum, which is mainly com-
posed of Purkinje cell dendrites and the parallel fiber 
axons of granule cells, was significantly decreased (Fig. 
2B) in comparison with that of the control autopsy cases, 
reflecting the marked loss of Purkinje cells and granule 
cells in the MD patients.
 The chief neuropathological characteristic in the 
cytoplasm of the residual Purkinje cells of MD patients 
was somatic sprouts (Fig. 2C). The neuropathological 
abnormalities of the dendrites of the residual Purkinje 
cells in MD patients included expansion and cactus-
like changes, i. e., partial enlargement of Purkinje cell 
dendrites was observed (Fig. 2D). With respect to ab-
normal dendritic arborization in the residual Purkinje 
cells, we observed downward extension of the dendrites, 
which has been called the weeping willow pattern by 
Kato et al.5 (Fig. 2E). In the granule cell layer of MD 
patients, the presence of heterotopic Purkinje cells bear-
ing somatic sprouts was noted (Fig. 2F). In addition, the 
residual Purkinje cells of MD patients displayed axonal 
expansions that are known as torpedoes (Fig. 2G).
 
Quantitative analysis of Purkinje cell changes 
The mean number (± SE) of residual Purkinje cells in 
all 7 MD autopsy cases was 9.1 ± 2.1 cells/3 mm. In 
contrast, the mean number (± SE) of Purkinje cells in 
the normal cerebellum at the age of 1 to 9 years, 10 to 
19 years, 20 to 29 years, 30 to 39 years, 40 to 49 years 
and 50 to 59 years was 20.1 ± 0.4 cells/3 mm, 20.1 ± 
0.4 cells/3 mm, 20.0 ± 0.6 cells/3 mm, 19.9 ± 0.5 cells/3 
mm, 19.9 ± 0.6 cells/3 mm and 19.2 ± 0.4 cells/3 mm, 
respectively (Fig. 3). There was a significant decrease 
of Purkinje cells in the MD patients compared with the 
number of cells in the controls (P < 0.01, Kruskal-Wallis 
test with ANOVA). We also performed a comparison 
between the number of residual Purkinje cells in MD 
patients and the number of Purkinje cells in normal chil-
dren from the age of 1 to 9 years. As a result, there was 
a significant decrease in the number of Purkinje cells 
in the MD patients (P < 0.01, Wilcoxon rank-sum test). 
Furthermore, we performed between-group analyses 
to compare the number of residual Purkinje cells in the 
Fig. 3. Quantitative analysis of the number of Purkinje cells in the cerebellum. The number of Purkinje cells in each autopsy case is 
shown as mean ± SE. Compared with the number of Purkinje cells in the normal controls, the number of Purkinje cells was significantly 
low in the MD patients. Error bars represent SE. *P < 0.01 compared with the normal control autopsy cases by Kruskal-Wallis analysis of 
variance, followed by the Wilcoxon rank-sum test.
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MD patients with the number of Purkinje cells in the 
normal control autopsy cases from age 10 to 19, from 
Fig. 4. Immunohistochemical expression of CCS (A–D) and SOD1 (E) by the Purkinje cells of a normal control.
A: Almost all of the Purkinje cells in the normal cerebellum are stained by the antibody for CCS (arrowheads and arrow), while granule 
cells (GC) do not react with the anti-CCS antibody (CCS immunostaining without counterstaining). Bar = 500 μm.
B: Higher magnification of the Purkinje cells identified by arrowheads in A. The cell bodies (arrowheads with C) and dendrites (arrow-
heads with D) are readily seen (CCS immunostaining without counterstaining). Bar = 100 μm. 
C: Higher magnification of the Purkinje cells indicated by an arrow in A. The cell body (arrowhead with C), primary dendrites (arrowhead 
with P), secondary dendrites (arrowhead with S) and tertiary dendrites (arrowhead with T), as well as an axon (arrowhead with AX), 
are clearly seen (CCS immunostaining without counterstaining). Bar = 100 μm. 
D: High-powered view of the Purkinje cell dendrites indicated by the arrowhead with S and arrowhead with T in C. Many spiny branch-
lets (arrowhead with sB) are clearly observed (CCS immunostaining without counterstaining). Bar = 30 μm. 
E and F: Preparations of the same section of normal control cerebellar cortex stained with anti-SOD1 antibody (E) or with HE (F). 
Almost all of the Purkinje cells in the normal control cerebellum are stained by the anti-SOD1 antibody with varying intensity. 
Purkinje cell bodies (arrowheads with C) are positive, as are their main dendrites, including the primary dendrites (arrowhead with P) 
and secondary dendrites (arrowhead with S) (E: SOD1 immunostaining without counterstaining. F: HE staining). Bars = 100 μm. 
CCS, copper chaperone for superoxide dismutase; HE, hematoxylin and eosin; SOD1, cytosolic Cu/Zn-superoxide dismutase. 
age 20 to 29, from age 30 to 39, from age 40 to 49 and 
from age 50 to 59 years. All of these analyses revealed 
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a significant decrease in the number of Purkinje cells 
in the MD patients (P < 0.01, Wilcoxon rank-sum test) 
(Fig. 3). In contrast, the number of Purkinje cells in the 
normal control autopsy cases showed no significant dif-
ference across the age groups from 1 to 59 years (P > 0.2, 
Kruskal-Wallis test with ANOVA). 
 
Immunohistochemical findings 
When control tissue sections were incubated with PBS, 
no immunoreaction products were seen. In the normal 
controls, Purkinje cells were stained by the antibody for 
CCS. Staining of the cell bodies, dendrites, and axons 
was seen, with the primary, secondary and tertiary den-
drites as well as spiny branchlets being clearly detected 
(Figs. 4A–D). The axons could be traced to the dentate 
Fig. 5. Immunostaining of the cerebellum of a normal control with antibodies for HNE (A), acrolein (C) and hsp 32 (E). Normal Purkinje 
cells (arrowheads) are not stained by the antibodies for HNE (A), acrolein (C) and hsp 32 (E).
A: HNE immunostaining with weak hematoxylin counterstaining. Bar = 100 μm.
C: Acrolein immunostaining with weak hematoxylin counterstaining. Bar = 100 μm.
E: hsp32 immunostaining with weak hematoxylin counterstaining. Bar = 100 μm.
B, D, F: HE staining. Bars = 100 μm.
HE, hematoxylin and eosin; HNE, 4-hydroxy-2-nonenal; hsp, heat shock protein. 
nucleus. The glial cells, myelin sheaths, blood vessels, 
leptomeninges and other neuronal cells of the normal 
cerebellum did not react with the anti-CCS antibody.
 Purkinje cells of the normal cerebellum were also 
immunostained by the anti-SOD1 antibody, with the cell 
bodies and the main dendrites (including primary and 
secondary dendrites) being positive (Figs. 4E and F). 
Normal Purkinje cells did not show immunostaining by 
the antibodies for HNE (Fig. 5A), acrolein (Fig. 5C) or 
hsp 32 (Fig. 5E).
 The surviving cerebellar Purkinje cells of MD 
patients differed from normal Purkinje cells in terms 
of both morphology and immunoreactivity. Residual 
Purkinje cells in MD patients showed immunostaining 
by the anti-CCS antibody at varying intensities and ap-
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proximately 77% (773 ± 49.5/1,000) of these cells were 
positive for CCS (Fig. 6A). The most frequent immunos-
taining pattern was varying levels of CCS positivity in 
the cell bodies and the proximal parts of the dendrites of 
the Purkinje cells.
 Immunostaining for SOD1 was positive in some of 
the surviving Purkinje cells of the MD patients, with 
the positive rate for anti-SOD1 antibody being about 
23% (232 ± 89.0/1,000) but the staining intensity was 
low (Fig. 6B). When SOD1-positive and SOD1-negative 
Purkinje cells of the MD patients were compared by HE 
staining, it was impossible to clearly distinguish between 
them (Fig. 6C).
 Immunostaining using anti-HNE antibody showed 
that many of the residual Purkinje cells were positive 
for HNE in MD patients. A variable staining intensity 
was observed (Fig. 7A), and the positive rate for anti-
HNE antibody among the surviving Purkinje cells 
was approximately 56% (564 ± 55.8/1,000). When 
HNE-positive and HNE-negative Purkinje cells were 
compared by HE staining, it was not possible to ob-
serve any clear differences between them (Fig. 7B). 
Immunostaining with the anti-acrolein antibody dem-
onstrated that some of the viable Purkinje cells in MD 
Fig. 6. Immunostaining of the cerebellum from a patient with MD using antibodies for CCS (A) and SOD1 (B).
A: Many of the surviving Purkinje cells are positive for CCS at varying intensities (CCS immunostaining without counterstaining). Bar 
= 200 μm.
B and C: Some of the surviving Purkinje cells (arrow in B and C) are positive for SOD1, while other cells (arrowhead in B and C) are 
negative (B: SOD1 immunostaining without counterstaining, C: HE staining). Bars = 200 μm.
CCS, copper chaperone for superoxide dismutase; HE, hematoxylin and eosin; MD, Menkes kinky hair disease; SOD1, cytosolic Cu/Zn-
superoxide dismutase.
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patients were positive for acrolein. A variable staining 
intensity was observed (Fig. 7C), and the positive rate 
for anti-acrolein antibody was approximately 42% (420 
± 94.1/1,000) among the residual Purkinje cells. When 
acrolein-positive and acrolein-negative Purkinje cells 
were compared by HE staining, no marked differences 
between them were observed (Fig. 7D). Immunostain-
ing with the anti-hsp 32 antibody showed that some of 
the residual Purkinje cells of MD patients were posi-
tive for hsp 32. There was variation of the staining in-
tensity (Fig. 7E), and the positive rate for anti-hsp 32 
antibody was approximately 40% (396 ± 73.5/1,000) 
among the residual MD Purkinje cells. When hsp 
32-positive and hsp 32-negative Purkinje cells were 
compared by HE staining, there were no clear differ-
ences between them (Fig. 7F). 
  
DISCUSSION
In the present neuropathological study of MD patients, 
marked loss of Purkinje cells and granule cells was ob-
Fig. 7. Immunostaining of the cerebellum from a patient with MD using antibodies for HNE (A), acrolein (C) and hsp 32 (E).
A and B: Some of the remaining Purkinje cells (arrowhead in A and B) are positive for HNE, while other cells (arrow in A and B) are 
negative (A: HNE immunostaining without counterstaining. B: HE staining). Bar = 100 μm.
C and D: Some residual Purkinje cells are positive for acrolein (arrowhead in C and D), while other residual Purkinje cells are not (arrow 
in C and D) (C: acrolein immunostaining without counterstaining. D: HE staining). Bar = 100 μm.
E and F: Some of the remaining Purkinje cells (arrowhead in E and F) are immunoreactive for hsp 32, while other cells are not (arrow 
in E and F) (E: hsp 32 immunostaining without counterstaining. F: HE staining). Bar= 100 μm.
HNE, 4-hydroxy-2-nonenal; HE, hematoxylin and eosin; hsp, heat shock protein; MD, Menkes kinky hair disease.
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served in the cerebellum. The residual Purkinje cells had 
the following neuropathological characteristics: somatic 
sprouts, cactus-like dendritic expansions, weeping wil-
low extension of dendrites, heterotopia and axonal torpe-
does.
 Somatic sprouts are observed in Purkinje cells of 
the normal fetus around 27 weeks at autopsy.4, 5 How-
ever, somatic sprouts are not observed in the normal 
fetus much past 27 weeks of gestation, so the sprouts 
disappear with increasing maturation.4, 5 Thus, somatic 
sprouts are part of the normal developmental process, 
but should not be seen after birth. The fact that somatic 
sprouts were noted in all of the 7 MD autopsy cases (aged 
from 1 year and 1 month to 6 years and 4 months) sug-
gests that the Purkinje cells of patients with MD have 
been affected by maldevelopment or developmental dis-
order.
 Ectopic Purkinje cells were present in the granule 
cell layer of the cerebellum in MD autopsy cases, but not 
in the normal control autopsy cases. Purkinje cells origi-
nate from the neural tube and pass through the granule 
cell layer while migrating toward the Purkinje cell layer 
of the cerebellum.30 Thus, normal migration results in 
Purkinje cells reaching the Purkinje cell layer, so the 
observation that MD patients have ectopic Purkinje cells 
suggests that these cells were arrested in the process of 
migrating toward the Purkinje cell layer and also indi-
cates maldevelopment. Furthermore, based on the find-
ing that ectopic Purkinje cells with somatic sprouts were 
present, cerebellar Purkinje cells in MD patients show 
evidence of maldevelopment.
 The finding of weeping willow and cactus-like 
changes indicated abnormal enlargement of some den-
drites. Dendritic expansion and cactus-like changes are 
assumed to arise during the process of dendrites extend-
ing from the Purkinje cell body. From this point of view, 
neuropathological findings such as dendritic expansion 
and cactus-like changes can be interpreted as further 
evidence of maldevelopment. On the other hand, it is 
also possible that after the Purkinje cell dendrites had de-
veloped fully, some dendrites underwent expansion and 
cactus-like changes due to degeneration. Thus, the neuro-
pathology of dendritic expansion and cactus-like changes 
could be related to both maldevelopment and degenera-
tion.
 When development is normal, the dendrites of Pur-
kinje cells extend from the cell bodies through the cer-
ebellar molecular layer toward the side of the subarach-
noid space. In contrast, the neuropathological weeping 
willow pattern is characterized by downwardly extending 
dendrites, and can be considered to arise from failure of 
the normal development of Purkinje cell dendrites. In this 
case, the weeping willow pattern is regarded as evidence 
of maldevelopment. On the other hand, the weeping wil-
low pattern can also be interpreted as evidence of degen-
eration. There is a possibility that after the dendrites of 
Purkinje cells have fully developed, downward extension 
of some dendrites occurs as a result of shrinkage of their 
arborization. In other words, the weeping willow pattern 
could be regarded as due to maldevelopment and/or de-
generation.
 Axonal torpedoes of Purkinje cells like those in MD 
patients are frequently observed in autopsy cases of oli-
vo-ponto-cerebellar atrophy, which is one of the neuro-
degenerative diseases.31 Therefore, the axonal torpedoes 
seen in MD patients may be an indicator of degeneration.
 Taken together, these findings indicate that cerebel-
lar MD Purkinje cells undergo cell death due to both 
maldevelopment and degeneration. Comparison of the 
number of Purkinje cells in the 7 MD patients with that 
in the 39 normal controls revealed that almost half of the 
Purkinje cells had been lost in the MD patients. Thus, 
we clearly demonstrated that 50% of the Purkinje cells in 
MD patients died due to the effects of maldevelopment 
and degeneration.
 There have been few reports about quantitative 
measurement of the number of Purkinje cells in the cer-
ebellum. To the best of our knowledge, there is only one 
report by Hausmann et al.32 concerning quantitative mea-
surement of the number of Purkinje cells in normal au-
topsy cases. They studied 52 autopsy cases aged between 
5 and 82 years and reported that the number of Purkinje 
cells per 1 mm length was 9.21 cells in 12 cases of sud-
den death and 7.60 cells in 18 cases of drowning or as-
phyxia that resulted in death within 10 min. In our study, 
the number of Purkinje cells was approximately 20.1 
cells per 3 mm length in 39 normal control autopsy cases 
in the aged between 1 and 59 years. In the present study, 
patients exhibiting normal cerebellar histology who died 
because of organ failure and disorders outside the central 
nervous system were used as normal controls. None of 
them were cases of sudden deaths due to unknown etiol-
ogy. When we assess the data of Hausmann et al. from 
this standpoint, our normal control group is similar to 
their 18 patients who died within 10 min due to drown-
ing or asphyxia. Hausmann’s data regarding the number 
of Purkinje cells could be converted to 22.8 cells per 3 
mm length and this number is very close to our result 
for measurement of the number of Purkinje cells in the 
controls. Such concordance suggests the validity of the 
results of our quantitative analysis of the number of cere-
bellar Purkinje cells in normal controls and MD patients. 
In addition, we found that the number of Purkinje cells 
showed no significant difference among the age groups, 
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from the group less than 10 years old to the group in their 
50s. Based on our data, the number of Purkinje cells in 
the normal cerebellum remains almost constant from 1 
year to 59 years old.
 Immunohistochemistry showed clear CCS staining 
from the cell bodies to the peripheral spiny branchlets of 
Purkinje cells. This immunohistochemical pattern sug-
gests that CCS is an abundant protein in normal Purkinje 
cells. Similarly, SOD1 protein was abundant in normal 
Purkinje cells and was expressed from the cell body to 
the major dendrites. On the other hand, in MD patients 
with copper deficiency, the percentage of residual Pur-
kinje cells positive for SOD1 was only about 23% and the 
intensity of staining was weak. In contrast, 77% of the re-
maining Purkinje cells were positive for CCS, which was 
higher than the rate for SOD1. In addition, the staining 
intensity for CCS was similar to that of normal control 
Purkinje cells. In other words, expression of CCS protein 
was maintained in MD Purkinje cells, but SOD1 protein 
was decreased. 
 There have been several reports about the levels 
of SOD1 and CCS protein in fresh tissues of copper-
deficient animals. Bertinato et al.33 fed one group of 
male Wistar rats a copper-deficient diet, while another 
group received a normal diet without copper deficiency, 
and they examined the levels of SOD1 and CCS protein 
in the liver and red blood cells of both groups by the 
western blotting method. SOD1 protein levels in both 
the liver and red blood cells were lower in the group 
receiving the copper-deficient diet compared with the 
group receiving a normal diet. In contrast, CCS protein 
levels were higher in both the liver and red blood cells of 
the group receiving the copper-deficient diet than in the 
group receiving a normal diet.33 Prohaska et al.34 used 
Holtzman rats and ND4 Swiss Webster mice to semi-
quantitatively examine the levels of SOD1 and CCS pro-
tein in the liver and brain of copper-deficient diet groups 
and non-copper-deficient normal diet groups by western 
blot analysis. SOD1 protein levels were lower in the liver 
and brain of rats and mice from the copper-deficient 
groups than in those of rats and mice from the normal 
diet groups. SOD1 protein levels in the livers of rats 
and mice were 30% and 70%, respectively, while brain 
SOD1 protein levels were 83% and 22%, respectively. 
In contrast, CCS protein levels in the livers and brains 
of rats and mice from the copper-deficient diet groups 
were increased by approximately 3-fold in the rat liver, 
approximately 1.7-fold in the mouse liver, approximately 
1.8-fold in the rat brain and approximately 2.8-fold in the 
mouse brain compared with the normal diet groups.34 
Furthermore, Gybina and Prohaska35 compared cerebel-
lar levels of CCS between Holtzman rats in the copper-
deficient diet and normal diet groups. Compared with 
the CCS protein level in the normal diet group, the CCS 
protein level in the cerebellum of rats from the copper-
deficient diet group was about 2-fold higher.35
 In MD patients, Purkinje cells were exposed to cop-
per deficiency for a very long period ranging from 1 
year and 1 month to 6 years and 4 months, because MD 
is a copper absorption disorder. Copper deficiency is as-
sumed to lead to a decrease of SOD1 protein, which is a 
copper-dependent enzyme. The duration of copper defi-
ciency was only 42 days in the study of Bertinato,33 23 
to 30 days in that of Prohaska34 and 24 to 27 days in that 
of Gybiana.35 Even with such short periods of copper 
deficiency, a decrease of SOD1 protein was observed in 
these animal experiments.33–35 In our study, immunohis-
tochemical staining showed that SOD1 expression was 
decreased in the residual Purkinje cells of MD patients. 
This reflected the fact that MD Purkinje cells had been 
subjected to severe damage caused by free radicals due 
to the chronic decrease of SOD1 activity. Under such 
circumstances, it would be difficult for the Purkinje cells 
of MD patients to maintain normal functions. On the 
other hand, while cell damage caused by free radicals 
secondary to the decrease of SOD1 could have occurred 
in the animal models of short-term copper deficiency, 
cell death was not observed.33–35 This suggested that 
Purkinje cells were protected and survived as a result of 
up-regulating CCS, which specifically transports copper 
to SOD1. This up-regulation of CCS in the animals with 
short-term copper deficiency might correspond to the 
protective response of CCS in the remaining Purkinje 
cells of MD patients with chronic copper deficiency. Ac-
cording to our immunohistochemical results, even in the 
remaining Purkinje cells of MD patients that were close 
to the moribund state, CCS was maintained at almost 
the normal level. Based on this finding, the mechanism 
of CSS up-regulation still had a protective effect in the 
residual Purkinje cells of MD patients.
 Our immunohistochemical analysis of HNE, ac-
rolein and hsp 32 demonstrated that normal cerebellar 
Purkinje cells did not express any of HNE, acrolein or 
hsp 32. In the Purkinje cells of MD patients, however, 
we observed expression of HNE, acrolein and hsp 32 
at varying intensities. The rate of positive staining for 
HNE, acrolein and hsp 32 in the remaining Purkinje 
cells of MD patients was 56%, 42% and 40%, respec-
tively. HNE is a cytotoxic product that is generated when 
polyunsaturated fatty acids such as arachidonic acid 
are subjected to oxidative stress, and acrolein is another 
toxic metabolite generated when lipid membranes are 
subjected to oxidative stress. Therefore, immunohisto-
chemical detection of both HNE and acrolein in the sur-
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viving Purkinje cells of MD patients is strong evidence 
of oxidative stress. On the other hand, the immunohisto-
chemical study also showed that hsp 32 was induced in 
the surviving Purkinje cells of MD patients. This could 
be regarded as evidence that hsp 32 was up-regulated in 
the surviving Purkinje cells as a self-protective mecha-
nism against oxidative stress to promote survival. Kato 
et al.4, 5 studied the expression of both hsp 27 and hsp 72 
in the residual Purkinje cells of MD patients, and their 
results indicated that induction of both hsp 27 and hsp 
72 occurs via a self-protective mechanism similar to that 
of hsp 32.4, 5
 In conclusion, the present study demonstrated that i) 
in MD, approximately 50% of the Purkinje cells in the 
cerebellum die due to maldevelopment and degeneration. 
ii) In the residual Purkinje cells of patients with this dis-
ease, CCS expression is close to normal as a protective 
response to a decrease of SOD1 activity due to chronic 
copper deficiency. iii) In response to the increase of oxi-
dative stress due to decreased SOD1 activity, hsp 32 is 
also induced as another protective mechanism.    
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